Newsroom
Category
September 10, 2019
UT Health San Antonio researchers have discovered a novel way to kill cancers that are caused by an inherited mutation in BRCA1, the type of cancer for which actress Angelina Jolie had preventive double mastectomy and reconstructive surgery in 2013. “This represents a new treatment for inherited breast and ovarian cancer, which are higher in […]
August 27, 2019
UT Health San Antonio researchers have discovered a novel way to kill cancers that are caused by an inherited mutation in BRCA1, the type of cancer for which actress Angelina Jolie had preventive double mastectomy and reconstructive surgery in 2013. “This represents a new treatment for inherited breast and ovarian cancer, which are higher in […]
August 20, 2019
Daruka Mahadevan, M.D., Ph.D., will also lead the hematology and medical oncology service line within the Mays Cancer Center.
August 19, 2019
The St. Baldrick’s Foundation has awarded $306,000 to David Libich, Ph.D., of UT Health San Antonio to further his studies of the childhood cancer Ewing sarcoma.
August 6, 2019
His current research interest is to investigate the BRCA1/2 tumor suppressor networks.
June 10, 2019
Researchers at UT Health San Antonio, in collaboration with the University of Texas at San Antonio, have developed a new class of drugs called capsazepine analogs, which bear structural similarities to capsaicin. In preclinical testing on mice, the drugs have shown promise in dramatically reducing the size of tumors. See the Express-News coverage of this […]